
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Supplements and Featured Publications
over 27 years ago
Participating Facultyover 27 years ago
An Introduction to SERMS and Their Gynecologic Effectsover 27 years ago
Selective Estrogens and Breast Tissueover 27 years ago
Discussionover 27 years ago
Selected Abstractsover 27 years ago
CME Quizover 27 years ago
Bibliographyover 27 years ago
Skeletal Effects of Selective Estrogen Receptor Modulators





